Replicate design [RSABE / ABEL]

posted by ElMaestro  – Denmark, 2011-04-21 15:04 (5545 d 21:52 ago) – Posting: # 6931
Views: 11,411

Hello Andrew,

❝ To my mind, it should be possible (in theory, at least) to make a BE comparison of Reference vs Reference (or Test vs Test) from the data derived from a BE study with a 4-period replicate design. Despite being a statistical epsilon semi-moron, I can still see that there must be a problem with the fact that in this design each volunteer receives the second dose of Reference after the first dose of Reference (doh!), whether they received the sequence TRTR or RTRT. In other words, there is only one sequence for Reference (or Test). Presumably this must interfere with proper determination of BE. How should one deal with this?


"A cosmic mind-f#%&er" as one of my sailors would call it.
If I understand your post correctly, your worry seems to be whether patient X is in sequence RR or in sequence RR :-D. Sequence, however, is a between-factor. Try and run the standard model without sequence as a factor on your ref data. And try for comparison to run a normal 2-period study without Sequence as a factor.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
248 visitors (0 registered, 248 guests [including 15 identified bots]).
Forum time: 12:56 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5